Analyst firms · DA Davidson · PHR
DA Davidson PHR price target and rating history
Phreesia Inc. (PHR) · Consumer Discretionary
DA Davidson rates Phreesia Inc. (PHR) Buy with a $33 price target, as of its latest action on Sep 5, 2025. It has published 3 rating actions on PHR since October 2022, including 1 upgrade and 0 downgrades. Across 9 firms with a PHR price target in the last 12 months, the median target is $11.
- Current rating
- Buy
- Price target
- $33
- Median target, all firms
- $11
- Actions on PHR
- 3
DA Davidson price target on PHR
Every DA Davidson rating on PHR
- Sep 5, 2025
- Jan 17, 2024
- Oct 13, 2022
How other firms rate PHR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Mkt Perform | Sep 8, 2026 | |
| Piper Sandler | Neutral | $12 | May 28, 2026 |
| Wells Fargo | Equal Weight | $9 | May 20, 2026 |
| Barclays | Equal Weight | $10 | May 15, 2026 |
| Citizens JMP | Mkt Perform | Apr 1, 2026 | |
| Robert W. Baird | Neutral | $10 | Mar 31, 2026 |
| Truist Securities | Hold | $11 | Mar 31, 2026 |
| Citigroup | Neutral | $10 | Mar 31, 2026 |
| Needham | Buy | $14 | Mar 31, 2026 |
| RBC Capital Markets | Outperform | $26 | Jan 9, 2026 |
| BMO Capital Markets | Outperform | $32 | Nov 13, 2025 |
Questions about DA Davidson and PHR
- What is DA Davidson's price target for PHR?
- DA Davidson's latest stated price target for Phreesia Inc. (PHR) is $33, from its action on Sep 5, 2025.
- What is DA Davidson's rating on PHR?
- DA Davidson rates PHR Buy, a bullish rating, as of Sep 5, 2025.
- When did DA Davidson last change its view on PHR?
- On Sep 5, 2025, DA Davidson resumes coverage at Buy, price target $33.
- How does DA Davidson's PHR target compare with other analysts?
- Across 9 firms with a PHR price target in the last 12 months, the median target is $11.
More PHR rating histories
All DA Davidson ratingsPHR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.